EVELETH, DAVID,JENKINS-EVELETH, JENNIFER,SUBRAMANIAM, AMUTHAKANNAN,BRADSHAW, RALPH
申请号：
CA3062473
公开号：
CA3062473A1
申请日:
2018.05.04
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
Described herein are modified fibroblast growth factor (FGF) polypeptides, pharmaceutical compositions and medicaments that include such modified FGF polypeptides, and methods of using such modified FGF polypeptides to treat or prevent conditions that benefit from administration of FGFs.
